AB Soft The Brief Pain Inventory ii User Manual
Page 24
43
5.
Cowan DT, Wilson-Barnett J, Griffiths P, Vaughan DJ, Gondhia
A, Allan LG. A randomized, double-blind, placebo-controlled,
cross-over pilot study to assess the effects of long-term opioid
drug consumption and subsequent abstinence in chronic
noncancer pain patients receiving controlled-release
morphine. Pain Med 6(2): 113-121, 3/2005.
6.
Galer BS, Sheldon E, Patel N, Codding C, Burch F, Gammaitoni
AR. Topical lidocaine patch 5% may target a novel underlying
pain mechanism in osteoarthritis. Curr Med Res Opin 20(9):
1455-1458, 9/2004.
7.
Gammaitoni AR, Galer BS, Lacouture P, Domingos J,
Schlagheck T. Effectiveness and safety of new
oxycodone/acetaminophen formulations with reduced
acetaminophen for the treatment of low back pain. Pain
Med 4(1): 21-30, 3/2003.
8.
Gerber L, el-Gabalawy H, Arayssi T, Furst G, Yarboro C,
Schumacher HR. Polyarticular arthritis, independent of
rheumatoid factor, is associated with poor functional
outcome in recent onset inflammatory synovitis. Journal of
Back and Musculoskeletal Rehabilitation 14(3): 105-109, 2000.
9.
Gerber LH, Furst G, Yarboro C, el-Gabalawy H. Number of
active joints, not diagnosis, is the primary determinant of
function and performance in early synovitis. Clin Exp
Rheumatol 21(5 Suppl 31): S65-S70, 9/2003.
10. Gimbel J, Linn R, Hale M, Nicholson B. Lidocaine patch
treatment in patients with low back pain: results of an open-
label, nonrandomized pilot study. Am J Ther 12(4): 311-319,
7/2005.
11. Gorodetskyi IG, Gorodnichenko AI, Tursin PS, Reshetnyak VK,
Uskov ON. Non-invasive interactive neurostimulation in the
post-operative recovery of patients with a trochanteric
fracture of the femur. Journal of Bone and Joint Surgery-British
Volume 89B(11): 1488-1494, 11/2007.
12. Gould E, Ma T. Back pain. Archives of Physical Medicine and
Rehabilitation 87(11): e38, 11/2006.
44
13. Kapstad H, Hanestad BR, Langeland N, Rustoen T, Stavem K.
Cutpoints for mild, moderate and severe pain in patients with
osteoarthritis of the hip or knee ready for joint replacement
surgery. BMC Musculoskelet Disord 9(1): 55, 4/2008.
14. Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of
bone: age-related changes and the anatomical distribution
of skeletal lesions. Osteoporos Int 19(1): 57-63, 1/2008.
15. Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of
bone: age-related changes and the anatomical distribution
of skeletal lesions. Osteoporos Int 19(1): 57-63, 1/2008.
16. Markenson JA, Croft J, Zhang PG, Richards P. Treatment of
persistent pain associated with osteoarthritis with controlled-
release oxycodone tablets in a randomized controlled clinical
trial. Clin J Pain 21(6): 524-535, 11/2005.
17. McDonald C, Wilson M, Todd J. 686 Butrans (Buprenorphine)
Transdermal Patches Improve Quality of Life in patients with
Osteoarthritis(OA). European Journal of Pain 10(Supplement
1): S179, 9/2006.
18. Mystakidou K, Parpa E, Tsilika E, Mavromati A, Smyrniotis V,
Georgaki S, Vlahos L. Long-term management of noncancer
pain with transdermal therapeutic system-fentanyl. J Pain 4(6):
298-306, 8/2003.
19. Pavelka K, Le L, X, Bjorneboe O, Herrero-Beaumont G, Richarz
U. Benefits of transdermal fentanyl in patients with rheumatoid
arthritis or with osteoarthritis of the knee or hip: an open-label
study to assess pain control. Curr Med Res Opin 20(12): 1967-
1977, 12/2004.
20. Portenoy RK, Farrar JT, Backonja MM, Cleeland CS, Yang K,
Friedman M, Colucci SV, Richards P. Long-term Use of
Controlled-release Oxycodone for Noncancer Pain: Results of
a 3-year Registry Study. Clin J Pain 23(4): 287-299, 5/2007.
21. Rosenthal M, Moore P, Groves E, Iwan T, Schlosser LG,
Dziewanowska Z, Negro-Vilar A. Sleep improves when patients
with chronic OA pain are managed with morning dosing of
once a day extended-release morphine sulfate (AVINZA):